Lensar (LNSR) Gains from Investment Securities (2019 - 2026)
Lensar (LNSR) reported Gains from Investment Securities of -$23.9 million for Q1 2026, down 6162.78% year-over-year from $395000.0 in Q1 2025, and down 23848.0% on a QoQ basis from -$100000.0 in Q4 2025.
Lensar (LNSR) has 8 years of Gains from Investment Securities data on file, last reported at -$23.9 million in Q1 2026.
- Quarterly Gains from Investment Securities fell 6162.78% year-over-year to -$23.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$32.2 million (down 8250.38% YoY) and the FY2025 annual result came in at $1.8 million, up 201.5% from the prior year.
- Gains from Investment Securities retreated to -$23.9 million in Q1 2026 per LNSR's latest filing, from -$100000.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $2.9 million in Q2 2023 and bottomed at -$23.9 million in Q1 2026.
- The 5-year median for Gains from Investment Securities is $86000.0 (2022), against an average of -$1.4 million.
- The widest annual swing landed in 2022, when Gains from Investment Securities jumped 377297.26%; it then plunged 49600.0% in 2024.
- Tracing LNSR's Gains from Investment Securities over 5 years: stood at $14000.0 in 2022, then tumbled by 278.57% to -$25000.0 in 2023, then plunged by 15156.0% to -$3.8 million in 2024, then jumped by 97.38% to -$100000.0 in 2025, then sank by 23848.0% to -$23.9 million in 2026.
- Per Business Quant, the three latest LNSR Gains from Investment Securities figures stand at -$23.9 million (Q1 2026), -$100000.0 (Q4 2025), and $642000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Lensar | 69.32 Mn | 69.61 Mn | 6.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.95 Mn |
| Mar 31, 2026 | -23.95 Mn |
| Dec 31, 2025 | -100,000.00 |
| Dec 31, 2025 | -100,000.00 |
| Sep 30, 2025 | 642,000.00 |
| Sep 30, 2025 | 642,000.00 |
| Jun 30, 2025 | -4.33 Mn |
| Jun 30, 2025 | -4.33 Mn |
| Mar 31, 2025 | 395,000.00 |
| Mar 31, 2025 | 395,000.00 |
| Dec 31, 2024 | -3.81 Mn |
| Dec 31, 2024 | -3.81 Mn |
| Sep 30, 2024 | 1.87 Mn |
| Sep 30, 2024 | 1.87 Mn |
| Jun 30, 2024 | 92,000.00 |
| Jun 30, 2024 | 92,000.00 |
| Mar 31, 2024 | -495,000.00 |
| Mar 31, 2024 | -495,000.00 |
| Dec 31, 2023 | -25,000.00 |
| Dec 31, 2023 | -25,000.00 |
| Sep 30, 2023 | 416,000.00 |
| Sep 30, 2023 | 416,000.00 |
| Jun 30, 2023 | 2.91 Mn |
| Jun 30, 2023 | 2.91 Mn |
| Mar 31, 2023 | 1,000.00 |
| Mar 31, 2023 | 1,000.00 |
| Dec 31, 2022 | 14,000.00 |
| Dec 31, 2022 | 14,000.00 |
| Sep 30, 2022 | 86,000.00 |
| Sep 30, 2022 | 86,000.00 |
| Jun 30, 2022 | 1.19 Mn |
| Jun 30, 2022 | 1.19 Mn |
| Mar 31, 2022 | 1.10 Mn |
| Mar 31, 2022 | 1.10 Mn |
| Sep 30, 2021 | 652.00 |
| Sep 30, 2021 | 652.00 |
| Jun 30, 2021 | 629.00 |
| Jun 30, 2021 | 629.00 |
| Mar 31, 2021 | 292.00 |
| Mar 31, 2021 | 292.00 |
| Sep 30, 2020 | -16,000.00 |
| Sep 30, 2020 | -16,000.00 |
| Jun 30, 2020 | -16,000.00 |
| Jun 30, 2020 | -16,000.00 |
| Mar 31, 2020 | 5,000.00 |
| Mar 31, 2020 | 5,000.00 |
| Dec 31, 2019 | 6,000.00 |
| Dec 31, 2019 | 6,000.00 |